Baby Formula Emergency Act

2022-05-18

Introduced in House

Baby Formula Emergency Act

This bill authorizes the President, during an infant formula shortage or potential shortage, to allow the production and marketing or duty-free importation of infant formula that meets specified criteria, regardless of Food and Drug Administration (FDA) requirements. The criteria include that the United States has not imposed any sanctions with respect to the manufacturer of the formula and the FDA has not determined that such formula is unsafe.

Further, the President must notify Congress about determinations related to supply shortages of infant formula.

]]>

text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.